OR WAIT null SECS
On the HCPLive sleep page, resources on the topics of medical news and expert insight into sleep medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sleep apnea, insomnia, narcolepsy, and more.
April 08, 2025
Article
Q1 2025 sleep updates include FDA rejecting pitolisant NDA for idiopathic hypersomnia, iptacopan improving PNH fatigue, and more.
March 13, 2025
A narrative review reports the connection between allergies and sleep and available treatment options for both conditions.
February 19, 2025
Pitolisant was evaluated for the supplemental indication in the phase 3 INTUNE study, which did not meet its primary outcome of reducing excessive daytime sleepiness.
January 15, 2025
2 phase 3 trials show iptacopan improves fatigue, quality of life, and hematologic markers in C5i-experienced or -naive patients with paroxysmal nocturnal hemoglobinuria.
January 14, 2025
A collaborative approach to patient sleep health
Subjective poor sleep quality is tied to greater systolic blood pressure in adults ≤ 49 years with optimal sleep duration, compared with adults ≥ 50 years.
January 08, 2025
This Month in Review captures 7 sleep medicine news, including FDA updates, from December 2024.
December 31, 2024
To celebrate the close of 2024, we're recapping the 10 most popular approval articles across the HCPLive Network of brands.
December 25, 2024
From FDA approvals to updated guidelines, 2024 brought transformative advancements in sleep medicine, offering new hope for managing complex sleep disorders.
December 20, 2024
Tirzepatide's approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.